Chimerix takes pivotal step for novel brain cancer drug
STORY HIGHLIGHTS Chimerix filed for FDA approval of dordaviprone for brain tumors. The drug targets a rare, aggressive tumor affecting children and young adults. Chimerix entered a $30 million loan agreement with Silicon Valley Bank. A drug company in …